Cancer therapy products was the top drug class advertising in medical journals in 2013

Top drug classes 2013

There were 95,765 print advertising pages published in medical journals in 2013, a 4% decrease year-over-year, according to Kantar Media. Cancer Therapy Products continue to be the top drug class advertising by both pages and dollars, as it was in 2012. Further, that product class comprised about 10% of total share. The Anticoagulants Oral class ranked second with 4% of share.

Top 5 Print Ad Drug Classes (Pages): Jan. – December 2013

  1. Cancer Therapy Products – 9,899 pages (+10%)
  2. Anticoagulants Oral – 4,023 pages (+28%)
  3. Diabetes Oral – 2,578 pages (+266%)
  4. Immunologic Agents – 1,831 pages (+100%)
  5. Diabetes Insulin – 1,754 pages (-33%)

The percentage changes compare 2013 to 2012. For more information on these ad insights or other data, let one of us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.

Search article